Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Beginning Cash Balance (2014 - 2026)

Mesoblast (MESO) posted Beginning Cash Balance of -$25.1 million for Q4 2022, down 141.45% sequentially from $60.4 million in Q3 2022.

Analysis

Mesoblast (MESO) Beginning Cash Balance (2014 - 2026) Analysis & Trends

Mesoblast has reported Beginning Cash Balance for 7 years, with the latest figure at -$25.1 million in Q4 2022.

  • Quarterly Beginning Cash Balance changed N/A year-over-year to -$25.1 million in Q4 2022, while the trailing twelve-month figure through Mar 2023 was $35.4 million (changed N/A YoY) and the FY2022 annual result came in at $136.9 million, up 5.84% from the prior year.
  • Beginning Cash Balance fell to -$25.1 million in Q4 2022 per MESO's latest filing, from $60.4 million in the prior quarter.
  • Over five years, Beginning Cash Balance peaked at $136.9 million in Q3 2021 and troughed at -$25.1 million in Q4 2022.
  • A 5-year average of $49.5 million and a median of $44.1 million in 2018 frame the typical range for Beginning Cash Balance.
  • The sharpest annual moves came in 2021 and 2022: Beginning Cash Balance surged 523.09% in 2021, then sank 55.84% in 2022.
  • Over 5 years, Beginning Cash Balance stood at $37.8 million in 2018, then jumped by 33.53% to $50.4 million in 2019, then sank by 57.95% to $21.2 million in 2020, then soared by 545.51% to $136.9 million in 2021, then sank by 118.3% to -$25.1 million in 2022.
  • According to Business Quant data, Beginning Cash Balance over the past three periods registered -$25.1 million, $60.4 million, and $136.9 million for Q4 2022, Q3 2022, and Q3 2021 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 161.55 Mn
Dec 31, 2025 161.55 Mn
Jun 30, 2025 62.96 Mn
Dec 31, 2024 62.96 Mn
Jun 30, 2024 71.32 Mn
Dec 31, 2023 71.32 Mn
Jun 30, 2023 60.45 Mn
Mar 31, 2023 60.45 Mn
Dec 31, 2022 60.45 Mn
Jun 30, 2022 136.88 Mn
Mar 31, 2022 136.88 Mn
Dec 31, 2021 136.88 Mn
Sep 30, 2021 136.88 Mn
Jun 30, 2021 129.33 Mn
Mar 31, 2021 129.33 Mn
Dec 31, 2020 129.33 Mn
Sep 30, 2020 129.33 Mn
Jun 30, 2020 50.43 Mn
Mar 31, 2020 50.43 Mn
Dec 31, 2019 50.43 Mn